Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies

References

• McIntyreRSWoldeyohannesHOSoczynskaJKThe prevalence and clinical characteristics associated with Diagnostic and Statistical Manual Version-5-defined anxious distress specifier in adults with major depressive disorder: results from the International Mood Disorders Collaborative ProjectTher Adv Chronic Dis20167315315927347362
   PubMed Web of Science ®Google Scholar
• ZimmermanMChelminskiIYoungDDalrympleKWalshERosensteinLA clinically useful self-report measure of the DSM-5 anxious distress specifier for major depressive disorderJ Clin Psychiatry201475660160724813209
   PubMed Web of Science ®Google Scholar
• FavaMRushAJAlpertJEDifference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D reportAm J Psychiatry2008165334235118172020
   PubMed Web of Science ®Google Scholar
• BrownTMDibenedettiDBDanchenkoNWeillerEFavaMSymptoms of anxiety and irritability in patients with major depressive disorderJ Depress Anxiety201653237
   Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders5th edArlington, VAAmerican Psychiatric Association2013
   Google Scholar
• FavaMAlpertJECarminCNClinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*DPsychol Med20043471299130815697056
   PubMed Web of Science ®Google Scholar
• TrivediMHThaseMEFavaMAdjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical featuresJ Clin Psychiatry200869121928193619192475
   PubMed Web of Science ®Google Scholar
• BandelowBBauerMVietaEExtended release quetiapine fumarate as adjunct to antidepressant therapy in patients with major depressive disorder: pooled analyses of data in patients with anxious depression versus low levels of anxiety at baselineWorld J Biol Psychiatry201415215516624506289
   PubMed Web of Science ®Google Scholar
• BauerMEl-KhaliliNDattoCSzamosiJErikssonHA pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorderJ Affect Disord20101271–3193020884063
   PubMed Web of Science ®Google Scholar
• MaedaKSuginoHAkazawaHBrexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulatorJ Pharmacol Exp Ther2014350358960424947465
   PubMed Web of Science ®Google Scholar
• ThaseMEYouakimJMSkubanAEfficacy and safety of adjunctive brexpiprazole 2 mg in major depressive disorder: a phase 3, randomized, placebo-controlled study in patients with inadequate response to antidepressantsJ Clin Psychiatry20157691224123126301701
   PubMed Web of Science ®Google Scholar
• ThaseMEYouakimJMSkubanAAdjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind studyJ Clin Psychiatry20157691232124026301771
   PubMed Web of Science ®Google Scholar
• HobartMSkubanAZhangPA randomized, placebo-controlled study of the efficacy and safety of fixed-dose brexpiprazole 2 mg/d as adjunctive treatment of adults with major depressive disorderJ Clin Psychiatry2018794pii: 17m12058
   Web of Science ®Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders4th ed text revisionWashington, DCAmerican Psychiatric Association2000
   Google Scholar
• ChandlerGMIosifescuDVPollackMHTargumSDFavaMRESEARCH: validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ)CNS Neurosci Ther201016532232519769599
   PubMed Web of Science ®Google Scholar
• HamiltonMA rating scale for depressionJ Neurol Neurosurg Psychiatry196023566214399272
   PubMed Web of Science ®Google Scholar
• MontgomerySAÅsbergMA new depression scale designed to be sensitive to changeBr J Psychiatry1979134382389444788
   PubMed Web of Science ®Google Scholar
• GuyWECDEU Assessment Manual for Psychopharmacology RevisedRockville, MDNational Institute of Mental Health1976
   Google Scholar
• McIntyreRSWeillerEZhangPWeissCBrexpiprazole as adjunctive treatment of major depressive disorder with anxious distress: results from a post-hoc analysis of two randomised controlled trialsJ Affect Disord201620111612327208498
   PubMed Web of Science ®Google Scholar
• RushAJGullionCMBascoMRJarrettRBTrivediMHThe inventory of depressive symptomatology (IDS): psychometric propertiesPsychol Med19962634774868733206
   PubMed Web of Science ®Google Scholar
• ClearyPGuyWFactor analysis of the Hamilton Depression ScaleDrugs Exp Clin Res197711–2115120
   Google Scholar
• ThaseMEZhangPSkubanAEfficacy of adjunctive brexpiprazole in patients with major depressive disorder: a clinical overviewCurr Psychiatry Rev2016123291301
   Google Scholar
• Rexulti® (Brexpiprazole) Tablets, for Oral Use [Prescribing Information]TokyoOtsuka Pharmaceutical Co., Ltd2018
   Google Scholar
• ZimmermanMClarkHMcGonigalPHarrisLGuzman HolstCMartinJRelationship between the DSM-5 anxious distress specifier and the Hamilton Depression Rating Scale anxiety/somatization factorJ Nerv Ment Dis2018206215215429373458
   PubMed Web of Science ®Google Scholar
• HamiltonMThe assessment of anxiety states by ratingBr J Med Psychol1959321505513638508
   PubMed Web of Science ®Google Scholar
• DavisLLOtaAPerryPTsuneyoshiKWeillerEBakerRAAdjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: an exploratory studyBrain Behav2016610e0052027781135
   PubMed Web of Science ®Google Scholar
• KomossaKDeppingAMGaudchauAKisslingWLeuchtSSecond-generation antipsychotics for major depressive disorder and dysthymiaCochrane Database Syst Rev201012CD008121
   PubMed Web of Science ®Google Scholar
• McIntyreRSWeillerEReal-world determinants of adjunctive antipsychotic prescribing for patients with major depressive disorder and inadequate response to antidepressants: a case review studyAdv Ther201532542944425968482
   PubMed Web of Science ®Google Scholar
• LiGTaljaardMvan den HeuvelERAn introduction to multiplicity issues in clinical trials: the what, why, when and howInt J Epidemiol201746274675528025257
   PubMed Web of Science ®Google Scholar